ライフサイエンスコーパス: Streptococcus pneumoniae

1 imicrobials and vaccine formulations against Streptococcus pneumoniae.

2 ia, including the major respiratory pathogen Streptococcus pneumoniae.

3 ongitudinal sampling of individuals carrying Streptococcus pneumoniae.

4 o efficacy against Staphylococcus aureus and Streptococcus pneumoniae.

5 ying protein interaction network in the host Streptococcus pneumoniae.

6 y intranasal infection with A66.1 serotype 3 Streptococcus pneumoniae.

7 eks later with PR8 influenza virus and A66.1 Streptococcus pneumoniae.

8 peron to copper homeostasis and virulence in Streptococcus pneumoniae.

9 esponse for the recognition and clearance of Streptococcus pneumoniae.

10 pathogens, namely, Staphylococcus aureus and Streptococcus pneumoniae.

11 neutrophils process IL-1beta in response to Streptococcus pneumoniae.

12 critical role in preventing pneumonia due to Streptococcus pneumoniae.

13 dent cytolysin (CDC) and virulence factor of Streptococcus pneumoniae.

14 cell wall biosynthesis and cell division of Streptococcus pneumoniae.

15 cluster in the Gram-positive human pathogen, Streptococcus pneumoniae.

16 pathogens, e.g., Streptococcus pyogenes and Streptococcus pneumoniae.

17 ent of pneumonia to the common lung pathogen Streptococcus pneumoniae.

18 suppresses the host immune responses against Streptococcus pneumoniae.

19 eumolysin (Ply) is a key virulence factor of Streptococcus pneumoniae.

20 of the most frequent bacterial colonizers is Streptococcus pneumoniae.

21 vasive bacterial infections mainly caused by Streptococcus pneumoniae.

22 of infection with either influenza virus or Streptococcus pneumoniae.

23 sing approach for efficient vaccines against Streptococcus pneumoniae.

24 ndary bacterial pneumonia, particularly from Streptococcus pneumoniae.

25 PD and challenged with opsonized serotype 14 Streptococcus pneumoniae.

26 so abrogating the virulence of the pathogen Streptococcus pneumoniae.

27 Th) 17 cells are important in the control of Streptococcus pneumoniae.

28 concept of this approach for 2 serotypes of Streptococcus pneumoniae.

29 owth of the major human respiratory pathogen Streptococcus pneumoniae.

30 y erm(B) confer most macrolide resistance in Streptococcus pneumoniae.

31 es was correlated with relative abundance of Streptococcus pneumoniae.

32 e the agglutination of specific serotypes of Streptococcus pneumoniae.

33 re used to test 10 Staphylococcus aureus, 10 Streptococcus pneumoniae, 10 Haemophilus influenzae, and

34 operative bile and wound infection cultures (Streptococcus pneumoniae, 114 cultures [47.9%] in instit

35 s: Neisseria meningitidis (1350 cases, 22%), Streptococcus pneumoniae (1143, 18%), Staphylococcus aur

36 Among bacteria Streptococcus pneumoniae (31.1%, N = 14) was isolated in

37 respiratory syncytial virus (60 [5.6%]), and Streptococcus pneumoniae (57 [5.3%]) were most commonly

38 on and inoculated with 80,000 CFU/100 mul of Streptococcus pneumoniae (6B) per naris.

39 ryngeal infection by S. pyogenes, but not by Streptococcus pneumoniae, a bacterium that does not prod

40 Streptococcus pneumoniae adherence to human epithelial c

41 Catabolism of galactose by Streptococcus pneumoniae alters the microbe's metabolism

42 Natural genetic transformation of Streptococcus pneumoniae, an important human pathogen, m

43 Streptococcus pneumoniae, an inhabitant of the upper res

44 he pneumonococcal capsular polysaccharide of Streptococcus pneumoniae and against the AD-2S1 peptide

45 y infection with influenza A virus (IAV) and Streptococcus pneumoniae and are the basis of effective

46 ureus in keratitis; Streptococcus viridians, Streptococcus pneumoniae and Coagulase negative Staphylo

47 Cocolonization by Streptococcus pneumoniae and Haemophilus influenzae amon

48 States for instance, Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae are

49 emonstrate the efficacy of this technique in Streptococcus pneumoniae and highlight the potential for

50 we use Ab-binding assays to demonstrate that Streptococcus pneumoniae and house dust mite (HDM) bear

51 R events in the gram-positive human pathogen Streptococcus pneumoniae and in the human genome.

52 Streptococcus pneumoniae and influenza viruses cause con

53 atory infection by the major human pathogens Streptococcus pneumoniae and Klebsiella pneumoniae.

54 al), with the major pathogens involved being Streptococcus pneumoniae and non-typeable Haemophilus in

55 Coinfections by Streptococcus pneumoniae and nontypeable Haemophilus inf

56 us aureus, Coagulase negative Staphylococci, Streptococcus pneumoniae and Pseudomonas aeruginosa are

57 ng affects both susceptibility to subsequent Streptococcus pneumoniae and Staphylococcus aureus infec

58 ions of genomes of the major human pathogens Streptococcus pneumoniae and Streptococcus pyogenes, SEE

59 ed several hundred-fold both by a bacterial (Streptococcus pneumoniae) and a viral infection (influen

60 istant Staphylococcus aureus, penicillin for Streptococcus pneumoniae, and an update on cephalosporin

61 pneumonia caused by Pseudomonas aeruginosa, Streptococcus pneumoniae, and Aspergillus fumigatus when

62 stillation of MS-WF, mice were infected with Streptococcus pneumoniae, and bronchoalveolar lavage flu

63 Swab specimens were tested for Streptococcus pneumoniae, and isolates underwent multilo

64 coli derived lipopolysaccharide, heat-killed Streptococcus pneumoniae, and Mycobacterium tuberculosis

65 fections caused by antibiotic-nonsusceptible Streptococcus pneumoniae (ANSP) continue to present an i

66 Respiratory viruses and Streptococcus pneumoniae are known to be copathogens in

67 Respiratory syncytial virus (RSV) and Streptococcus pneumoniae are major respiratory pathogens

68 e molecular identification and serotyping of Streptococcus pneumoniae are useful for culture-negative

69 Both Streptococcus pyogenes and Streptococcus pneumoniae are widely thought to rapidly d

70 pecific IgG responses to intact, heat-killed Streptococcus pneumoniae, as well as a soluble OVA-polys

71 ecalis ATCC 29212 (0.03 to 0.12 mug/ml), and Streptococcus pneumoniae ATCC 49619 (0.004 to 0.015 mug/

72 terococcus faecalis ATCC 29212 (broth only), Streptococcus pneumoniae ATCC 49619 (disk and broth), an

73 5922, Haemophilus influenzae ATCC 49247, and Streptococcus pneumoniae ATCC 49619.

74 CCR is likely of great importance to Streptococcus pneumoniae because the human host sites in

75 The pathogenesis of the disease caused by Streptococcus pneumoniae begins with colonization of the

76 lla catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae, but not other bacterial pathog

77 CXCL14 contributed to enhanced clearance of Streptococcus pneumoniae, but not Pseudomonas aeruginosa

78 Most children are transiently colonized with Streptococcus pneumoniae, but very few develop invasive

79 24%) were tested for respiratory viruses and Streptococcus pneumoniae by real-time polymerase chain r

80 of pneumolysin, the main virulence factor of Streptococcus pneumoniae, by cryoEM.

81 In mice, Streptococcus pneumoniae can invade the myocardium, indu

82 Structural characterization of Streptococcus pneumoniae capsular polysaccharides (CPS)

83 Infections with Streptococcus pneumoniae cause substantial morbidity and

84 ng toxins, such as Staphylococcus aureus and Streptococcus pneumoniae, cause a substantial burden of

85 Streptococcus pneumoniae caused approximately 30%-60% of

86 Before 1945, Streptococcus pneumoniae caused more than 90% of cases o

87 Streptococcus pneumoniae causes high mortality as a majo

88 n comparison with PCh-BSA and PCh-containing Streptococcus pneumoniae cell wall polysaccharide.

89 is, respectively, in the mid-cell regions of Streptococcus pneumoniae cells at different stages of di

90 screen for mutations affecting the growth of Streptococcus pneumoniae cells when the aPBP synthase PB

91 Streptococcus pneumoniae commonly inhabits the nasophary

92 In Streptococcus pneumoniae, competence develops transientl

93 In B. subtilis and Streptococcus pneumoniae, condensin complexes are enrich

94 Beta-lactam resistant clinical isolates of Streptococcus pneumoniae contain altered penicillin-bind

95 Streptococcus pneumoniae contributes considerably to the

96 he predominant P2X7R-expressing cells during Streptococcus pneumoniae corneal infection, and P2X7R wa

97 this study, we use glycoconjugates of type 3 Streptococcus pneumoniae CPS (Pn3P) to assess whether th

98 peptidoglycan from the midcells of dividing Streptococcus pneumoniae D39 background cells.

99 The respiratory pathogen Streptococcus pneumoniae deploys type IV pili to take up

100 Deletion of plsX (SP0037) in Streptococcus pneumoniae did not result in an auxotrophi

101 we have shown that the respiratory pathogen Streptococcus pneumoniae disables neutrophils by exploit

102 In Streptococcus pneumoniae, elevated sigma(X) is insuffici

103 higher in a Type I diabetic rabbit model of Streptococcus pneumoniae endophthalmitis.

104 lococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, Enterococcus faecalis, and Ent

105 Streptococcus pneumoniae expresses capsular polysacchari

106 The human pathogen Streptococcus pneumoniae expresses two different types o

107 In addition, in vivo infection with Streptococcus pneumoniae failed to induce PU.1 expressio

108 neumococcal disease, defined as isolation of Streptococcus pneumoniae from blood, cerebrospinal fluid

109 Reduction in yield of Streptococcus pneumoniae from NP culture was approximate

110 est and MALDI-TOF for the differentiation of Streptococcus pneumoniae from other mitis group streptoc

111 n their entirety or reliably differentiating Streptococcus pneumoniae from viridans streptococci.

112 the GTPase activity and assembly dynamics of Streptococcus pneumoniae FtsZ (SpnFtsZ).

113 ding proteins that Staphylococcus aureus and Streptococcus pneumoniae, Gram-positive bacterial pathog

114 strate that the opportunistic human pathogen Streptococcus pneumoniae grows in medium supplemented wi

115 owed a predominance of bacteria, principally Streptococcus pneumoniae, >75% being of serotypes covere

116 bocavirus) and 3 pathogenic airway bacteria (Streptococcus pneumoniae, Haemophilus influenzae, and Mo

117 Viral diagnostics and quantitative PCR for Streptococcus pneumoniae, Haemophilus influenzae, and Mo

118 us, coagulase-negative staphylococci (CoNS), Streptococcus pneumoniae, Haemophilus influenzae, and Ps

119 and Acanthamoeba), six bacterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Neisse

120 Streptococcus pneumoniae has demonstrated a remarkable a

121 ein response, and innate immune responses to Streptococcus pneumoniae has not been fully elucidated.

122 vaccines against Haemophilus influenzae and Streptococcus pneumoniae has virtually eliminated the co

123 targeting Haemophilus influenzae type b and Streptococcus pneumoniae have dramatically altered the e

124 (e.g., MRSA, VRE, PRSP (penicillin-resistant Streptococcus pneumoniae)); however, there are currently

125 domonas aeruginosa, Streptococcus mitis, and Streptococcus pneumoniae in a dose-dependent manner in p

126 Using Streptococcus pneumoniae in a well-established murine mo

127 d transmission of the opportunistic pathogen Streptococcus pneumoniae in an infant mouse model.

128 g the efficacy of geOMVs as vaccines against Streptococcus pneumoniae in mice, and against Campylobac

129 PCV7) has affected the genetic population of Streptococcus pneumoniae in pediatric carriage.

130 ing of the spleen, we identify a tropism for Streptococcus pneumoniae in this organ mediated by tissu

131 % of patients), influenza virus (in 6%), and Streptococcus pneumoniae (in 5%).

132 Haemophilus influenzae, Aspergillus species, Streptococcus pneumoniae) in bronchoalveolar lavage flui

133 However, the human pathogen Streptococcus pneumoniae, in common with many other orga

134 reased risk of pulmonary infection caused by Streptococcus pneumoniae, in particular during severe as

135 Streptococcus pneumoniae incidence fell from 0.8 per 100

136 Intact, inactivated Streptococcus pneumoniae [including the unencapsulated S

137 iring serious bacterial infections caused by Streptococcus pneumoniae, including pneumonia.

138 ncoding the only PP2C Ser/Thr phosphatase in Streptococcus pneumoniae, indicating that GpsB plays a k

139 amined the role C4 has in protection against Streptococcus pneumoniae-induced autoimmunity.

140 esults were demonstrated in a mouse model of Streptococcus pneumoniae-induced empyema.

141 of the alveolar barrier in a mouse model of Streptococcus pneumoniae-induced pneumonia, and ex vivo

142 xpression and its effect on inflammation and Streptococcus pneumoniae infection in mice.

143 the mechanistic effects of these factors on Streptococcus pneumoniae infection in mice.

144 tein (CRP) in protecting mice against lethal Streptococcus pneumoniae infection is unknown.

145 MP), and generated better protection against Streptococcus pneumoniae infection than 2'3'-cGAMP adjuv

146 o regulate the pathogen-host response during Streptococcus pneumoniae infection, but the role Chil1 p

147 es in cerebrospinal fluid from children with Streptococcus pneumoniae infection, compared with childr

148 survival in a mouse model of NLRP3-mediated Streptococcus pneumoniae infection.

149 ysaccharide and an impaired host response to Streptococcus pneumoniae infection.

150 Streptococcus pneumoniae infections are an important cau

151 Streptococcus pneumoniae infections arising in hospitali

152 d PCV13) induce immunological memory against Streptococcus pneumoniae infections caused by vaccine se

153 es in protecting elderly individuals against Streptococcus pneumoniae infections is not clear.

154 Life-threatening Streptococcus pneumoniae infections often occur after he

155 ia meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae, inflicts a substantial burden

156 stridium difficile, anaerobes, Candida spp., Streptococcus pneumoniae, influenza, Mycobacterium tuber

157 The Streptococcus pneumoniae Invasive Disease network (SpIDn

158 s in the pre-PCV period, 34% were mixed with Streptococcus pneumoniae IRRs (95% confidence interval)

159 Streptococcus pneumoniae is a commensal of the human nas

160 Streptococcus pneumoniae is a common cause of otitis med

161 Streptococcus pneumoniae is a common colonizer of the hu

162 Streptococcus pneumoniae is a fermentative microorganism

163 Streptococcus pneumoniae is a human-adapted pathogen tha

164 The adhesion of Streptococcus pneumoniae is a key step during colonizati

165 Binding of C4BP to Streptococcus pneumoniae is a known virulence mechanism

166 Streptococcus pneumoniae is a leading cause of invasive

167 Streptococcus pneumoniae is a leading cause of invasive

168 Streptococcus pneumoniae is a leading cause of pneumonia

169 Streptococcus pneumoniae is a major bacterial pathogen i

170 Streptococcus pneumoniae is a major causative pathogen i

171 Streptococcus pneumoniae is a major cause of life-threat

172 Streptococcus pneumoniae is a major cause of life-threat

173 The Gram-positive bacterium Streptococcus pneumoniae is a major human pathogen that

174 Streptococcus pneumoniae is a nasopharyngeal commensal t

175 Streptococcus pneumoniae is a significant bacterial path

176 Streptococcus pneumoniae is a significant human pathogen

177 Streptococcus pneumoniae is an important human pathogen

178 Serotype-specific protection against Streptococcus pneumoniae is an important limitation of t

179 Streptococcus pneumoniae is an opportunistic pathogen th

180 Streptococcus pneumoniae is both a commensal and a major

181 Pulmonary infection by Streptococcus pneumoniae is characterized by a robust al

182 tend our knowledge on the mechanisms whereby Streptococcus pneumoniae is cleared by the spleen.

183 resolution microscopy, report that PBP2x of Streptococcus pneumoniae is directed to a discrete locat

184 el et al. (2014) report that colonization of Streptococcus pneumoniae is facilitated by coinfection w

185 at the activation of macrophage NF-kappaB by Streptococcus pneumoniae is highly diverse, with a prepo

186 Streptococcus pneumoniae is one of the most common bacte

187 Streptococcus pneumoniae is responsible for diseases cau

188 Streptococcus pneumoniae is the leading cause of communi

189 Because Streptococcus pneumoniae is the leading cause of communi

190 Streptococcus pneumoniae is the main cause of bacterial

191 Streptococcus pneumoniae is the most common bacterial et

192 Streptococcus pneumoniae is the most common causative or

193 Streptococcus pneumoniae is the most common causative pa

194 Streptococcus pneumoniae is the most common causative pa

195 Streptococcus pneumoniae is the most common cause of bac

196 Streptococcus pneumoniae is the most common cause of com

197 Streptococcus pneumoniae is the most common cause of pne

198 Streptococcus pneumoniae is the world's leading cause of

199 cial cell wall constituent of the pathobiont Streptococcus pneumoniae, is bound to peptidoglycan (wal

200 We analyzed whole genome sequences of 1,680 Streptococcus pneumoniae isolates from four independent

201 ection of human airway epithelial cells with Streptococcus pneumoniae leads to induction of endoplasm

202 followed by the noninvasive EF3030 strain of Streptococcus pneumoniae, leads to a significant decreas

203 phis infected with the common lung pathogens Streptococcus pneumoniae, Legionella pneumophila, or Myc

204 Streptococcus pneumoniae, like many other naturally tran

205 systematically sampled genomes, we show that Streptococcus pneumoniae lineages are typically characte

206 r macrophages for host immunity during early Streptococcus pneumoniae lung infection is well establis

207 the role of IL-22-IL-22R is understudied in Streptococcus pneumoniae lung infection, a prevalent pat

208 fection on bacterial carriage and density of Streptococcus pneumoniae, Moraxella catarrhalis, Haemoph

209 se bacterial species: Staphylococcus aureus, Streptococcus pneumoniae, Mycobacterium tuberculosis, Sa

210 s were Streptococcus viridans (n = 47; 71%), Streptococcus pneumoniae (n = 13; 21%), and beta-hemolyt

211 [n = 5], Haemophilus influenzae [n = 5], and Streptococcus pneumoniae [n = 5]), and transport medium

212 An increase in Streptococcus pneumoniae nasopharynx (NP) colonization d

213 tination for bacterial antigen) and qPCR for Streptococcus pneumoniae, Neisseria meningitidis, and Ha

214 so-called conventional bacterial infections (Streptococcus pneumoniae, Neisseria meningitidis, Haemop

215 In children aged <5 years, Streptococcus pneumoniae, nontyphoidal salmonellae (NTS)

216 Evasion of clinical interventions by Streptococcus pneumoniae occurs through selection of non

217 philus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae (odds ratio [OR], 3.27; 95% con

218 ls were stimulated in vitro with heat-killed Streptococcus pneumoniae or CD3/CD28 antibodies and stai

219 intratracheally with Klebsiella pneumoniae, Streptococcus pneumoniae, or lipopolysaccharide.

220 al [CI] = 3.27-5.37; n = 2432 participants), Streptococcus pneumoniae otitis media (OR = 2.51; 95% CI

221 ue hypoxia-ischemia are strongly linked with Streptococcus pneumoniae pathogenesis in patients with s

222 f Enterococcus faecium (fnm), a homologue of Streptococcus pneumoniae pavA, in the genomes of E. faec

223 acet of the interaction between the pathogen Streptococcus pneumoniae (pneumococcus) and its human ho

224 The prevalence of Streptococcus pneumoniae (pneumococcus) carriage is high

225 Streptococcus pneumoniae (pneumococcus) is a leading cau

226 Streptococcus pneumoniae (pneumococcus) is a major human

227 Streptococcus pneumoniae (pneumococcus) is a major human

228 Streptococcus pneumoniae (pneumococcus) is an oval-shape

229 Streptococcus pneumoniae (pneumococcus) is both a widesp

230 The competence regulon of Streptococcus pneumoniae (pneumococcus) is crucial for g

231 he least understood aspects of the bacterium Streptococcus pneumoniae (pneumococcus) is its transmiss

232 Streptococcus pneumoniae (pneumococcus) is the primary c

233 Streptococcus pneumoniae (pneumococcus) produces hydroge

234 Streptococcus pneumoniae (pneumococcus) produces many ca

235 ped ovococcus bacteria, such as the pathogen Streptococcus pneumoniae (pneumococcus), side-wall (peri

236 e-wall like) peptidoglycan (PG) synthesis in Streptococcus pneumoniae (pneumococcus); yet, mechanisms

237 These studies tested the role of Nrf2 during Streptococcus pneumoniae pneumonia and identified Nrf2-d

238 e presentation and outcomes of patients with Streptococcus pneumoniae pneumonia.

239 Streptococcus pneumoniae produces a protective capsular

240 Streptococcus pneumoniae produces pneumolysin toxin as a

241 ediated hemolysis of ES PspCN, a CFH-binding Streptococcus pneumoniae protein domain, binds CFH tight

242 spectrometry, that the N-terminal domain of Streptococcus pneumoniae protein PspC (PspCN) not only b

243 Several Streptococcus pneumoniae proteins play a role in pathoge

244 tion of energy, the important human pathogen Streptococcus pneumoniae relies on host-derived sugars,

245 Pneumococcus (Streptococcus pneumoniae) remains a significant cause of

246 on of infant rats with increasing inocula of Streptococcus pneumoniae resulted in a dose-dependent in

247 Neisseria meningitidis (N. meningitidis), Streptococcus pneumoniae (S. pneumoniae), and Haemophilu

248 Streptococcus pneumoniae serotype 1 has a high likelihoo

249 Streptococcus pneumoniae serotype 1 is one of the leadin

250 Using the Streptococcus pneumoniae serotype 2 CPS, which is synthe

251 Streptococcus pneumoniae serotype 3 strains emerge frequ

252 Streptococcus pneumoniae serotype 35B is a nonvaccine se

253 eak was due to multiple pathogens, including Streptococcus pneumoniae serotype 5 and influenza viruse

254 Streptococcus pneumoniae serotypes differ in clinical ma

255 Some Streptococcus pneumoniae serotypes express an ahemolytic

256 The divergent epidemiological behavior of Streptococcus pneumoniae serotypes suggests that serotyp

257 ble PCR primers were designed to distinguish Streptococcus pneumoniae serotypes within serogroup 18 f

258 ting invasive pneumococcal disease caused by Streptococcus pneumoniae Some components of the S. pneum

259 Populations of Streptococcus pneumoniae (SP) are typically structured i

260 Streptococcus pneumoniae (SP) is a pathogenic bacterium

261 ly cover only 13 of the over 90 serotypes of Streptococcus pneumoniae (Sp), so nonvaccine serotypes a

262 ulence of important human pathogens, such as Streptococcus pneumoniae (Sp).

263 with the family 98 glycoside hydrolase from Streptococcus pneumoniae SP3-BS71 (Sp3GH98), which cleav

264 topoisomerase IV (ParE) from a G(+) strain (Streptococcus pneumoniae (sParE)) and a G(-) strain (Pse

265 Streptococcus pneumoniae-specific plasmablasts presumabl

266 virus URIs on the frequency of AOM caused by Streptococcus pneumoniae (Spn) and nontypeable Haemophil

267 y we characterize the PaaI thioesterase from Streptococcus pneumoniae (SpPaaI), including structural

268 ane disruption, against the airway pathogens Streptococcus pneumoniae, Staphylococcus aureus, Nontype

269 monstrated against Staphylococcus aureus and Streptococcus pneumoniae strains.

270 teria monocytogenes, Neisseria meningitidis, Streptococcus pneumoniae, Streptococcus agalactiae, cyto

271 y Bacillus subtilis, Streptococcus pyogenes, Streptococcus pneumoniae, Streptococcus mutans, Staphylo

272 Streptococcus pneumoniae strongly up-regulated MIF produ

273 ng Escherichia coli, Bacillus anthracis, and Streptococcus pneumoniae, studies in mycobacteria have n

274 Streptococcus pneumoniae (the pneumococcus) is a human p

275 Streptococcus pneumoniae (the pneumococcus) is capable o

276 Streptococcus pneumoniae (the pneumococcus) is the leadi

277 Streptococcus pneumoniae (the pneumococcus) is the world

278 Even in the vaccine era, Streptococcus pneumoniae (the pneumococcus) remains a le

279 s is a prerequisite for the human pathobiont Streptococcus pneumoniae (the pneumococcus) to cause sev

280 Streptococcus pneumoniae (the pneumococcus), a leading c

281 In Streptococcus pneumoniae, the core enzyme GtfA and co-ac

282 their ability to combat microbes, including Streptococcus pneumoniae, the most common cause of CAP i

283 In Streptococcus pneumoniae, the positive regulatory mechan

284 In a number of bacterial species, including Streptococcus pneumoniae, the prevalence of resistance h

285 bset of pathogenic microorganisms, including Streptococcus pneumoniae, the recognition and degradatio

286 For Streptococcus pneumoniae, the transition to severe lower

287 c domain comprising a fragment of GH101 from Streptococcus pneumoniae TIGR4, SpGH101, in the absence

288 ative data for the pattern of disease due to Streptococcus pneumoniae, trends in the serotype of inva

289 related to the capsular polysaccharide from Streptococcus pneumoniae type 37, which consists of a be

290 lysin pneumolysin, a key virulence factor of Streptococcus pneumoniae, using single cell studies.

291 MRSA and 22 (1.0%) with MSSA; 115 (5.1%) had Streptococcus pneumoniae Vancomycin or linezolid was adm

292 he commensal genus Neisseria and the species Streptococcus pneumoniae was associated with lower EAC r

293 Streptococcus pneumoniae was detected more frequently in

294 Streptococcus pneumoniae was the most frequently isolate

295 In Streptococcus pneumoniae, we find a genomically and ecol

296 ildren (107/6769); Staphylococcus aureus and Streptococcus pneumoniae were most commonly identified.

297 Haemophilus influenzae and Streptococcus pneumoniae were the main agents detected,

298 ity-acquired pneumonia is commonly caused by Streptococcus pneumoniae, which is associated with exces

299 beta-lactam and co-trimoxazole resistance in Streptococcus pneumoniae with accuracies ranging from 88

300 PspC) are key players for the interaction of Streptococcus pneumoniae with matricellular hTSP-1.